EBS vs HAL · rev $1.04B vs P/E 9.3, $19.05B cap
Emergent Biosolutions Inc (EBS) versus Halliburton Company (HAL) — a side-by-side from cached financials, not a winner call.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
HAL does not have a complete income-statement cache yet.
EBS currently screens at market cap $416.4M. HAL currently screens at market cap $19.05B and trailing P/E 9.3.
Not investment advice. Open the EBS and HAL stock pages for the full models.
Not investment advice.